Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update

/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a...

Related Keywords

Kiki Patel ,Richa Kumari ,James Levine ,Gilmartin Group ,Nasdaq ,Cardiff Oncology Inc ,Taft Communications ,Cardiff Oncology ,Oncology Contact ,Nc ,